pb909, thanks for your reply and info.
The study is to compare effectiveness of the 3 new oral meds, includes monthly 3D MRIs, and monthly monitoring of blood work and MS neuro office visits.
I assume it's a relatively small study compared to others. It's being conducted at Providence MS Center and Harvard MS Center. The center directors at these 2 institutions presented nearly identical proposals for their 'dream' study. I think the proposals were presented to Aubagio pharma.
It's posted on the Tec, Gelynia? and Aubagio threads.
The study is to compare effectiveness of the 3 new oral meds, includes monthly 3D MRIs, and monthly monitoring of blood work and MS neuro office visits.
I assume it's a relatively small study compared to others. It's being conducted at Providence MS Center and Harvard MS Center. The center directors at these 2 institutions presented nearly identical proposals for their 'dream' study. I think the proposals were presented to Aubagio pharma.
It's posted on the Tec, Gelynia? and Aubagio threads.
Comment